Annemieke Cats

Amsterdam, NH 1066CX, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 137 publications

Pharmacokinetics of 5-Fluorouracil in Patients Treated With Capecitabine Carrying the c.1236G>A DPYD Variant Allele.

Pharmacokinetics of 5-Fluorouracil in Patients Treated With Capecitabine Carrying the c.1236G>A DPYD Variant Allele.

Journal: JCO precision oncology

Published: June 08, 2026

Neoadjuvant Bevacizumab and Chemoradiotherapy for Locally Advanced Rectal Cancer: Long-Term Outcomes of a Multicentre Study.

Neoadjuvant Bevacizumab and Chemoradiotherapy for Locally Advanced Rectal Cancer: Long-Term Outcomes of a Multicentre Study.

Journal: Clinical colorectal cancer

Published: March 26, 2026

Predictors of poor treatment tolerability in older patients receiving fluoropyrimidine-based chemotherapy: A prospective cohort study.

Predictors of poor treatment tolerability in older patients receiving fluoropyrimidine-based chemotherapy: A prospective cohort study.

Journal: Journal of geriatric oncology

Published: October 21, 2025

Clinical response to capecitabine in a DPYD*2A homozygous patient: Case report and therapeutic guidance.

Clinical response to capecitabine in a DPYD*2A homozygous patient: Case report and therapeutic guidance.

Journal: British journal of clinical pharmacology

Published: October 21, 2025

Response to Letter Re: Dose-individualisation of fluoropyrimidines based on pre-treatment serum uracil levels.

Response to Letter Re: Dose-individualisation of fluoropyrimidines based on pre-treatment serum uracil levels.

Journal: European journal of cancer (Oxford, England : 1990)

Published: September 04, 2025

Dose-individualisation of fluoropyrimidines based on pre-treatment serum uracil levels: the Alpe2U study.

Dose-individualisation of fluoropyrimidines based on pre-treatment serum uracil levels: the Alpe2U study.

Journal: European journal of cancer (Oxford, England : 1990)

Published: February 04, 2025

A novel approach to assess the prognostic value of toxicity profiles in gastric cancer patients undergoing preoperative treatment.

A novel approach to assess the prognostic value of toxicity profiles in gastric cancer patients undergoing preoperative treatment.

Journal: European journal of cancer (Oxford, England : 1990)

Published: February 03, 2025

Hereditary diffuse gastric cancer spectrum associated with germline CTNNA1 loss of function revealed by clinical and molecular data from 351 carrier families and over 37 000 non-carrier controls.

Hereditary diffuse gastric cancer spectrum associated with germline CTNNA1 loss of function revealed by clinical and molecular data from 351 carrier families and over 37 000 non-carrier controls.

Journal: Gut

Published: December 16, 2024

Severe fluoropyrimidine toxicity in older adults with cancer with DPYD wild type.

Severe fluoropyrimidine toxicity in older adults with cancer with DPYD wild type.

Journal: Fundamental & clinical pharmacology

Published: June 28, 2024

Histopathological response to chemotherapy and survival of mucinous type gastric cancer.

Histopathological response to chemotherapy and survival of mucinous type gastric cancer.

Journal: Journal of the National Cancer Institute

Published: April 10, 2024

Tumor immune microenvironmental characteristics in Human Epidermal Growth Factor-2 (HER2) positive esophageal adenocarcinoma: A comparative analysis and biomarker study.

Tumor immune microenvironmental characteristics in Human Epidermal Growth Factor-2 (HER2) positive esophageal adenocarcinoma: A comparative analysis and biomarker study.

Journal: Translational oncology

Published: April 08, 2024

Discovering novel germline genetic variants linked to severe fluoropyrimidine-related toxicity in- and outside DPYD.

Discovering novel germline genetic variants linked to severe fluoropyrimidine-related toxicity in- and outside DPYD.

Journal: Genome medicine

Published: March 29, 2024

Showing 1-12 of 137

Last Updated: 09/26/2026